LESLIE MORGAN: Open Payments
NPI 1518218999 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$748 in 34 payments from 13 companies in 2025. Trend: 2023 $508 · 2024 $612 · 2025 $748
Food & beverage: $673Education: $75
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $309 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $103 |
| Aveo Pharmaceuticals, Inc. | 1 | $75 |
| Novartis Pharmaceuticals Corporation | 2 | $50 |
| Iovance Biotherapeutics, Inc. | 1 | $37 |
| TerSera Therapeutics LLC | 1 | $28 |
| Lundbeck LLC | 1 | $26 |
| UCB, Inc. | 1 | $25 |
| Genentech USA, Inc. | 1 | $25 |
| Neurelis, Inc. | 1 | $21 |
Products named: BOTOX, FOTIVDA, IMBRUVICA, Fabhalta, ICLUSIG, QULIPTA, Amtagvi, FRUZAQLA.
Industry payments across MD — which companies pay providers there.
